15d-PGJ(2) is acting as a 'dual agent' on the regulation of COX-2 expression in human osteoarthritic chondrocytes

Osteoarthritis Cartilage. 2002 Nov;10(11):845-8. doi: 10.1053/joca.2002.0835.

Abstract

The PGD(2) metabolite 15-deoxy-delta12,14 PGJ(2) (15d-PGJ(2)), a potent peroxisome proliferator-activated receptor gamma (PPARgamma) activator, has recently received attention for its potential antiinflammatory effects, but its effect on the cyclooxygenase-2 (COX-2) production is still under debate. We investigated the effect of 15d-PGJ(2) on COX-2 and prostaglandin E(2) (PGE(2)) production in the absence or the presence of interleukin-1beta (IL-1beta) in human osteoarthritic chondrocytes.Data showed that, as expected, IL-1beta induced both COX-2 and PGE(2) production. The addition of 15d-PGJ(2) completely blocked (by 93%) the IL-1beta-induced PGE(2) synthesis, whereas COX-2 level was only partially reduced (by 72%). Interestingly in the absence of any COX-2 inducer, 15d-PGJ(2) up-regulated COX-2 expression without concomitant elevation of PGE(2) synthesis. This study showed that the PPARgamma agonist, 15d-PGJ(2), exerts a dual effect on COX-2 production. The mechanisms by which 15d-PGJ(2) favors COX-2 production will be discussed.

MeSH terms

  • Chondrocytes / drug effects
  • Chondrocytes / metabolism
  • Cyclooxygenase 2
  • Dinoprostone / biosynthesis*
  • Humans
  • Immunologic Factors / pharmacology*
  • Interleukin-1 / metabolism*
  • Isoenzymes / biosynthesis*
  • Membrane Proteins
  • Osteoarthritis, Knee / metabolism*
  • Peroxidases / biosynthesis*
  • Prostaglandin D2 / analogs & derivatives
  • Prostaglandin D2 / pharmacology*
  • Prostaglandin-Endoperoxide Synthases / biosynthesis*
  • Up-Regulation

Substances

  • 15-deoxy-delta(12,14)-prostaglandin J2
  • Immunologic Factors
  • Interleukin-1
  • Isoenzymes
  • Membrane Proteins
  • Peroxidases
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone
  • Prostaglandin D2